Medikamentöse Therapiemaßnahmen bei akuter SARS-CoV-2-Infektion: wer, wann und was?

Related Research units

Abstract

There is a variety of drug therapy options for treatment of acute SARS-CoV-2 infections. The updated S3 guideline "Recommendations for inpatient therapy of patients with COVID-19" provides clear recommendations in this regard. Which therapy is best suited for which patient and in which phase of the disease must be decided individually based on risk factors, comorbidities and contraindications. This article provides an overview.

Bibliographical data

Translated title of the contributionDrug therapy interventions for acute SARS-CoV-2 infection: who, when, and what?
Original languageGerman
ISSN0934-8387
DOIs
Publication statusPublished - 01.2023

Comment Deanary

Thieme. All rights reserved.

PubMed 36691378